Valeur202020212022202320242025TTMFrais de vente, généraux et administratifs3.18 B3.32 B2.76 B2.84 B2.93 B3.26 B3.35 BRecherche et développement372 M497.2 M406 M458.7 M437.4 M458.5 M451.3 MRésultat d'exploitation-87.8 M780.1 M696.3 M1.28 B1.29 B1.1 B1.18 BTotal des produits hors exploitation2.6 M8.1 M-239.3 M-28.4 M-57.2 M26 M-1.1 MCharges d'intérêts, nettes des intérêts capitalisés———————Résultat hors exploitation, hors charges d'intérêts-22.8 M-3.7 M-111.3 M-19.1 M-26.1 M500 K-20.7 MRevenus/dépenses exceptionnels25.4 M11.8 M-128 M-9.3 M-31.1 M25.5 M19.6 MRésultat avant impôts-274.4 M418.4 M403.5 M1.07 B1.04 B830.8 M903.1 MPart des actionnaires dans le résultat———————Impôts-137 M16.3 M112.3 M42.2 M131.4 M125.7 M142.2 MIntérêts ne donnant pas le contrôle / intérêts minoritaires1.5 M500 K—————Autres produits/charges après impôts———————Résultat net avant activités abandonnées-138.9 M401.6 M290.2 M1.08 B962.6 M705.1 M761.2 MActivités abandonnées——-58.8 M-58.8 M-58.8 M——Résultat net-138.9 M401.6 M231.4 M1.02 B903.8 M705.1 M761.2 MAjustement de dilution———————Dividendes privilégiés———————Résultat net dilué revenant aux actionnaires ordinaires-138.9 M401.6 M231.4 M1.02 B903.8 M705.1 M761.2 MBénéfice par action de base (BPA de base)-0.671.931.14.914.453.563.86Bénéfice par action dilué (BPA dilué)-0.671.911.14.884.433.553.86Nombre moyen d'actions de base en circulation207 M208.6 M209.6 M208.7 M203.1 M198 M—Nombre d'actions en circulation après dilution207 M210.4 M210.3 M209.7 M203.9 M198.7 M—EBITDA1.16 B2.06 B1.79 B2.43 B2.5 B1.9 B1.99 BEBIT-299.8 M571.7 M531.5 M1.08 B1.07 B805.3 M883.6 MCoût des ventes2.13 B2.34 B2.02 B2.08 B2.19 B2.49 B2.52 BAutres coûts des ventes250 M181.7 M137.3 M155.2 M149.9 M311.2 M—Amortissements (flux de trésorerie)1.03 B1.07 B926.4 M951.7 M996.3 M1.09 B1.11 B
Zimmer Biomet Holdings, Inc. Common Stock
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet.
On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook.